Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
0.9940
+0.0240 (2.47%)
At close: Jan 16, 2026, 4:00 PM EST
0.9600
-0.0340 (-3.42%)
After-hours: Jan 16, 2026, 6:41 PM EST
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $41.78 million as of January 16, 2026. Its market cap has decreased by -3.76% in one year.
Market Cap
41.78M
Enterprise Value
40.16M
1-Year Change
-3.76%
Ranking
Category
Stock Price
$0.99
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $41.78M, an increase of 2,250.47%. That is a compound annual growth rate of 164.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 41.78M | -29.08% |
| Dec 31, 2025 | 58.91M | 35.70% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |